Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-08-16
2008-09-30
Shiao, Rei-tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S529000, C549S008000, C560S129000
Reexamination Certificate
active
07429615
ABSTRACT:
The invention relates to the use of novel cyclohexyl analogues of E-type prostaglandins as EP4agonists, in general, and, in particular as ocular hypotensives. The cyclohexyl analogues used in accordance with the invention are represented by the following formula I:wherein the wavy segments represent α or β bond, dashed line represents the presence or absence of a bond W, Y, Z, R, R1, R2and R3are as defined in the specification.
REFERENCES:
patent: 3985798 (1976-10-01), Floyd et al.
patent: 4007210 (1977-02-01), Bernady et al.
patent: 6531614 (2003-03-01), Conrow
patent: 7015243 (2006-03-01), Old et al.
Bernady et al., 1977, CAS:87:22543.
Lopez-Pelegrin et al., 2000, CAS: 134:71397.
Ohuchida et al. , 1984, CAS: 100: 209457.
Floyd et al., 1979, CAS: 90:54519.
Burk Robert M.
Dinh Thang D.
Old David W.
Allergan Inc.
Allergan, Inc.
Johnson Brent A.
Shiao Rei-tsang
Voet Martin
LandOfFree
Cyclohexyl prostaglandin analogs as EP 4 -receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclohexyl prostaglandin analogs as EP 4 -receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclohexyl prostaglandin analogs as EP 4 -receptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3983227